OR5W2: A Potential Drug Target for Neurodegenerative Diseases

OR5W2: A Potential Drug Target for Neurodegenerative Diseases

OR5W2 (OR5W3P), a protein that belongs to the OR5W family of cytoplasmic proteins, has been identified as a potential drug target (or biomarker) in the field of neurodegenerative diseases. OR5W2 is expressed in various tissues and cell types, including brain, spinal cord, and muscle, and is involved in various cellular processes such as cell adhesion, migration, and survival.

The OR5W2 protein is composed of 51 amino acid residues and has a molecular weight of 64 kDa. It is characterized by a N-terminal伪-helic acid loop, a 尾-sheet, and a C-terminal T-loop. OR5W2 is expressed in various tissues and cell types, including brain, spinal cord, and muscle, and has been shown to be involved in various cellular processes such as cell adhesion, migration, and survival.

One of the unique features of OR5W2 is its ability to form a complex with the protein N-cadherin, which is a critical regulator of cell-cell adhesion. This complex plays a role in the regulation of cellular processes such as cell growth, differentiation, and survival, and is implicated in the development and progression of neurodegenerative diseases.

In addition to its role in cell-cell adhesion, OR5W2 is also involved in the regulation of cell migration and survival. It has been shown to play a role in the regulation of cell migration in various tissues, including the brain, and is involved in the development and progression of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

The potential drug targets for OR5W2 are numerous, and include the regulation of cell adhesion, migration, and survival, as well as the development of neurodegenerative diseases. OR5W2 has been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and survival, and is potential drug target for neurodegenerative diseases.

In conclusion, OR5W2 is a protein that has been identified as a potential drug target (or biomarker) for a variety of neurodegenerative diseases. Its unique ability to form a complex with the protein N-cadherin and its involvement in the regulation of cell adhesion, migration, and survival make it an attractive target for drug development. Further research is needed to fully understand the role of OR5W2 in neurodegenerative diseases and to develop effective treatments.

Protein Name: Olfactory Receptor Family 5 Subfamily W Member 2

Functions: Odorant receptor

More Common Targets

OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4